International Journal of Oncology

Papers
(The TQCC of International Journal of Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
[Corrigendum] Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3‑kinase inhibitor (ZSTK474)182
Anti‑angiogenic effect of Bryopsis plumosa‑derived peptide via aquaporin 3 in non‑small cell lung cancer132
[Retracted] Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway117
Identification and characterization of slow‑cycling cells in Ewing sarcoma76
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways69
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals60
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer58
Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells58
snoRNAs and their derived sdRNAs: Emerging regulators, biomarkers, and therapeutic targets in human cancers (Review)57
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review)52
From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review)49
Unraveling the roles of fibroblast activation protein‑positive cancer‑associated fibroblasts in cancer: From mechanisms to therapy (Review)44
TGF‑β1 in cancer: From tumour suppressor to promoter, molecular mechanisms, and precision therapeutic strategies (Review)42
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes41
Role of miR‑181a‑5p in cancer (Review)39
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)38
[Retracted] Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis34
[Retracted] Feroniellin A‑induced autophagy causes apoptosis in multidrug‑resistant human A549 lung cancer cells33
Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response33
[Retracted] MicroRNA‑155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID232
GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A2032
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors30
[Retracted] Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma29
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer29
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression29
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)29
Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin28
RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)28
Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells28
Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol27
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)27
Understanding the epigenetic regulation of lactylation and aberrant lactate metabolism in cancer: From mechanisms to therapeutic strategies (Review)26
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)26
Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma26
[Corrigendum] HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-324
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review)24
[Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression24
[Corrigendum] (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation24
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)24
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization23
AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer23
Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation23
Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)23
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer23
Application of cfDNA methylation in cancer prognostic assessment: Progress and challenges (Review)23
Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway23
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review)23
[Expression of Concern] Establishment and evaluation of a new highly metastatic tumor cell line 5a‑D‑Luc‑ZsGreen expressing both luciferase and green fluorescent protein22
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway22
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)22
lncRNA AL445238.2‑USP4 axis regulates cell survival and stemness in colon cancer21
Role of miRNA‑122 in cancer (Review)21
[Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells21
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)21
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in breast cancer20
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)20
[Retracted] MicroRNA‑181a regulates epithelial‑mesenchymal transition by targeting PTEN in drug‑resistant lung adenocarcinoma cells20
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)20
An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)20
[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox420
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer20
A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma20
[Corrigendum] Podoplanin‑mediated TGF‑β‑induced epithelial‑mesen‑ chymal transition and its correlation with bHLH transcription factor DEC in TE‑11 cells19
[Retracted] NR4A1‑induced increase in the sensitivity of a human gastric cancer line to TNFα‑mediated apoptosis is associated with the inhibition of JNK/Parkin‑dependent mitophagy19
Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review)19
Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review)19
[Expression of Concern] MicroRNA‑195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways19
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway19
The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells19
[Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway19
Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL319
Role of DCLK1 in oncogenic signaling (Review)19
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway19
[Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma18
Ferroptosis in biliary tract cancer: Molecular mechanisms and therapeutic applications (Review)18
Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionality18
LGR4 promotes proliferation and homing via activation of the NF‑κB signaling pathway in multiple myeloma18
CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review)18
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells18
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)18
[Retracted] Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion17
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP917
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α17
RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells17
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)17
MicroRNA in adenoid cystic carcinoma (Review)16
[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells16
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review)16
Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review)16
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)16
Radiotherapy resistance in glioblastoma: Mechanistic insights and novel therapeutic approaches (Review)16
Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer16
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer16
Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review)16
Targeted therapy in BRAF‑mutant melanoma: Advances and challenges (Review)16
[Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration15
[Corrigendum] Leptin promotes breast cancer cell migration and invasion via IL‑18 expression and secretion15
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome15
Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review)15
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia15
[Expression of Concern] Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells15
[Retracted] Slug contributes to cancer progression by direct regulation of ERα signaling pathway14
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer14
P2X7 receptor: An emerging therapeutic target in acute myeloid leukemia14
[Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis14
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)14
[Retracted] lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma14
Roles of salt‑inducible kinases in cancer (Review)14
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling13
[Expression of Concern] Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase‑913
Targeting drug resistance in glioblastoma (Review)13
T‑box transcription factor 15 regulated by methyltransferase‑like 3‑mediated N6‑methyladenosine modification promotes immune escape and progression of gastric cancer by activating matrix metalloprotei13
Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer13
m6A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling13
[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma13
Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer13
Tumour follower cells: A novel driver of leader cells in collective invasion (Review)13
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells13
[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells13
Research advances in aptamers in the diagnosis and treatment of breast cancer (Review)13
[Retracted] Expression and function of PIM kinases in osteosarcoma13
Protein lactylation and immunotherapy in gliomas: A novel regulatory axis in tumor metabolism (Review)13
[Retracted] Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway13
Circular RNAs in osteosarcoma: An update of recent studies (Review)13
[Corrigendum] The mechanism of adenosine‑mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells13
IL‑6: A key player in the EGFR‑TKI‑resistant tumor microenvironment and its therapeutic implications (Review)12
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance12
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation12
Function of microRNA‑124 in the pathogenesis of cancer (Review)12
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma12
Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation12
ZBTB20 promotes ferroptosis through inhibiting TMEM109 expression in glioblastoma cells12
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)12
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)12
Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia12
1.6387338638306